ライフサイエンスコーパス: Klebsiella

1 tracellular pathogens, including Candida and Klebsiella.

2 16 to 29% and 0% of mice with Salmonella and Klebsiella administrations, respectively.

3 resistant members of the genera Escherichia, Klebsiella and Enterobacter, genera commonly associated

4 ated in 25 to 33% and 10 to 16% of mice with Klebsiella and Salmonella administrations, respectively.

5 ains of Gram-negative bacteria, Yersinia and Klebsiella, and less so by their wild-type counterparts.

6 Klebsiella bacteremia was demonstrated in 25 to 33% and

7 licon sequencing tool to screen patients for Klebsiella carriage could inform health care staff of th

8 lostridiales), the second by Proteobacteria (Klebsiella/Enterobacter), the third by Bacteriodetes, an

9 cificity superior to that of the MHT for non-Klebsiella Enterobacteriaceae.

10 To identify additional Klebsiella factors required to dampen inflammation, we s

11 LpxL2-dependent lipid A acylation protects Klebsiella from polymyxins, mediates resistance to phago

12 the largest differences observed involved a Klebsiella genus member (7.8-fold increase in patients w

13 was accompanied by enhanced phagocytosis of Klebsiella GPVI-depleted mice showed increased lung hemo

14 accordance, low PCs in whole blood enhanced Klebsiella-induced cytokine release in vitro.

15 the lung during pulmonary infection and that Klebsiella-induced mortality was significantly increased

16 e importance of this lipid A modification in Klebsiella infection biology.

17 itro with various stimuli and in vivo during Klebsiella infection.

18 he last options to treat multidrug-resistant Klebsiella infections, triggers the in vivo lipid A patt

19 Mannose-resistant Klebsiella-like (Mrk) hemagglutinins are critical for K

20 his study, we investigated the capability of Klebsiella mobilis to produce iron minerals in the prese

21 by Proteobacteria with Escherichia coli and Klebsiella most prevalent.

22 ent bacterial genera (Bacillus, Cupriavidus, Klebsiella, Ochrobactrum, Paenibacillus, Pseudomonas, an

23 . perfringens revealed an overabundance of a Klebsiella OTU (P = .049).

24 fecal microbiota signatures (Clostridium and Klebsiella OTUs) and need for prolonged CPAP oxygen sign

25 l target detections exceeded 96%, except for Klebsiella oxytoca (92.2%), which achieved 98.3% sensiti

26 Intriguingly, the OM protein CymA from Klebsiella oxytoca does not depend on TonB but neverthel

27 an agriculturally relevant gene cluster from Klebsiella oxytoca encoding the nitrogen fixation pathwa

28 tube subunits, Hcp1, is required for killing Klebsiella oxytoca in vitro and that this activity is me

29 We exploit the modularity of a refactored Klebsiella oxytoca nitrogen fixation (nif) gene cluster

30 ts rapid overgrowth of the enteric bacterium Klebsiella oxytoca results in antibiotic-associated hemo

31 Klebsiella oxytoca strain 11492-1 was isolated from a pe

32 r cloacae complex, Klebsiella pneumoniae, or Klebsiella oxytoca that were recovered from sterile-site

33 acing the pulE-K putative pilin genes of the Klebsiella oxytoca type II secretion system with the com

34 ia coli, 100%; Klebsiella pneumoniae, 92.9%; Klebsiella oxytoca, 95.5%; Enterobacter spp., 99.3%; Pse

35 ing Klebsiella pneumoniae, Escherichia coli, Klebsiella oxytoca, and Citrobacter freundii.

36 of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, and Proteus mirabilis with an ertape

37 D was originally discovered in the bacterium Klebsiella oxytoca, but it has recently been shown that

38 Enterobacter cloacae, Enterococcus faecalis, Klebsiella oxytoca, Klebsiella pneumoniae, and Staphyloc

39 bacter spp., Escherichia coli/Shigella spp., Klebsiella oxytoca, Klebsiella pneumoniae, Proteus spp.,

40 an atomic model for a T2SS pseudopilus from Klebsiella oxytoca, obtained by fitting the NMR structur

41 h CymA, a cyclodextrin-specific channel from Klebsiella oxytoca.

42 xhibited good antibacterial activity against Klebsiella planticola with MIC of 15.6mug/mL and compoun

43 , including members from the human pathogens Klebsiella pneumonia and Enterobacter aerogenes, and wou

44 olar lavage fluid from A(2B)R(-/-) mice with Klebsiella pneumonia contained more extracellular DNA co

45 t innate immune response to LPS stimulation, Klebsiella pneumonia infection or Mycobacterium tubercul

46 Klebsiella pneumonia infection rates have increased dram

47 is are powerful tools that can shed light on Klebsiella pneumonia infections.

48 The pathogenesis of Klebsiella pneumonia is linked to the bacteria's ability

49 ection, as shown by increased mortality in a Klebsiella pneumonia model.

50 res of Escherichia coli, Vibrio cholera, and Klebsiella pneumonia SlmA-DNA-FtsZ CTD ternary complexes

51 defenses during lethal pneumonia induced by Klebsiella pneumonia, compared to wild-type mice.

52 protected during lethal pneumonia induced by Klebsiella pneumonia, compared to wild-type mice.

53 unds show activity against Escherichia coli, Klebsiella pneumonia, Enterobacter cloacae, Acinetobacte

54 , Proteus mirabilis, Pseudomonas aeruginosa, Klebsiella pneumonia.

55 Murine acute pneumonia model induced by Klebsiella pneumonia.

56 teria (Pseudomonas aeruginosa, 16-32 mug/mL, Klebsiella pneumoniae > 32 mug/mL).

57 d intention-to-treat population (n=355) were Klebsiella pneumoniae (37%) and Pseudomonas aeruginosa (

58 The most frequent organism was Klebsiella pneumoniae (375 [86%] of 437; 291 [85%] of 34

59 odes due to Acinetobacter baumannii (46.4%), Klebsiella pneumoniae (46.4%), and Pseudomonas aeruginos

60 coli (28%), Burkholderia pseudomallei (11%), Klebsiella pneumoniae (9%), and Staphylococcus aureus (6

61 Infections caused by carpabenem-resistant Klebsiella pneumoniae (CR-Kp) are especially problematic

62 rgently needed to treat carbapenem-resistant Klebsiella pneumoniae (CR-Kp)-mediated infection, which

63 sortium on Resistance against Carbapenems in Klebsiella pneumoniae (CRACKLE) was constructed of patie

64 The rapid emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) represents a major public h

65 k of OXA-232-expressing carbapenem-resistant Klebsiella pneumoniae (CRKP) transmitted to 16 patients

66 e growing importance of carbapenem-resistant Klebsiella pneumoniae (CRKP), the clonal relationships b

67 or infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKp).

68 hia coli (ESBL-Ec; n = 72) or ESBL-producing Klebsiella pneumoniae (ESBL-Kp; n = 10) and their hospit

69 minant siderophore produced by hypervirulent Klebsiella pneumoniae (hvKP) and was previously shown to

70 New hypervirulent variants of Klebsiella pneumoniae (hvKP) are emerging globally, most

71 Hypervirulent Klebsiella pneumoniae (hvKP) is an emerging pathotype th

72 Hypervirulent (hypermucoviscous) Klebsiella pneumoniae (hvKP) strains are an emerging var

73 Two types of Klebsiella pneumoniae (KP) strains are currently emergin

74 Recently, in Klebsiella pneumoniae (Kp), PqqD and PqqE were shown to

75 ne domain of the Outer membrane protein A of Klebsiella pneumoniae (KpOmpA).

76 ase genes were most frequently identified in Klebsiella pneumoniae (n = 1,127), Escherichia coli (n =

77 Klebsiella pneumoniae (n = 180, 41.9%), Escherichia coli

78 y resistant isolates of Escherichia coli and Klebsiella pneumoniae (PRIMERS I).

79 ainst SP-A- and SP-B(N)-resistant capsulated Klebsiella pneumoniae (serotype K2) at neutral pH.

80 e species including Pseudomonas aeruginosa , Klebsiella pneumoniae , and Escherichia coli .

81 substitution in the SHV beta-lactamase, from Klebsiella pneumoniae , results in resistance to ampicil

82 , extended-spectrum beta-lactamase-producing Klebsiella pneumoniae [10], carbapenem-resistant Acineto

83 anavalin, Pichia pastoris lysyl oxidase, and Klebsiella pneumoniae acetolactate synthase.

84 colonization caused by carbapenem-resistant Klebsiella pneumoniae among profoundly immunocompromised

85 nterobacteriaceae isolates, 125 (94.7%) were Klebsiella pneumoniae and 74 harbored K. pneumoniae carb

86 ptococus pneumoniae, Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli in Conjunctiv

87 on the occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in European h

88 terferes with their cognate function against Klebsiella pneumoniae and Escherichia coli; vi) MAIT cel

89 (-/-) mice following airway exposure to LPS, Klebsiella pneumoniae and Mycobacterium tuberculosis.

90 sortium on Resistance Against Carbapenems in Klebsiella pneumoniae and Other Enterobacteriaceae) has

91 obacteriaceae, including multidrug-resistant Klebsiella pneumoniae and pathogenic Escherichia coli, r

92 ainst Enterococcus faecium, platinum against Klebsiella pneumoniae and platinum and silver against Ac

93 Klebsiella pneumoniae and Pseudomonas aeruginosa are mic

94 d extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Salmonella typhimurium.

95 Nosocomial infections with Klebsiella pneumoniae are a frequent cause of Gram-negat

96 , Micrococcus luteus, Bacillus subtilis, and Klebsiella pneumoniae at a minimal inhibitory concentrat

97 was hospitalized with septic shock caused by Klebsiella pneumoniae bacteremia.

98 ein A (TTPA) is a structural tail protein of Klebsiella pneumoniae bacteriophage KP32, and is respons

99 oteins from E. coli, Salmonella enterica and Klebsiella pneumoniae bind c-di-GMP via the domain of un

100 t SPLUNC1 (rSPLUNC1) significantly inhibited Klebsiella pneumoniae biofilm formation on airway epithe

101 CPOs carrying the Klebsiella pneumoniae carbapenemase (bla KPC ) gene have

102 duplex, real-time PCR assay for detection of Klebsiella pneumoniae carbapenemase (blaKPC) and New Del

103 detection of ertapenem (ETP) resistance and Klebsiella pneumoniae carbapenemase (KPC) in 47 Klebsiel

104 In the United States, the production of the Klebsiella pneumoniae carbapenemase (KPC) is an importan

105 ogy labs to perform confirmatory testing for Klebsiella pneumoniae carbapenemase (KPC) production or

106 Imipenemase (IMP), Klebsiella pneumoniae carbapenemase (KPC), and Verona in

107 n of serine carbapenemases, particularly the Klebsiella pneumoniae carbapenemase (KPC), with no inhib

108 In the United States, Klebsiella pneumoniae carbapenemase (KPC)-producing Ente

109 esent the first reported infection caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Ente

110 Two clinical strains of Klebsiella pneumoniae carbapenemase (KPC)-producing K. p

111 or detection of Enterobacteriaceae producing Klebsiella pneumoniae carbapenemase (KPC)-type carbapene

112 oncerning is the widespread dissemination of Klebsiella pneumoniae carbapenemase (KPC).

113 tam antibiotics due to the production of the Klebsiella pneumoniae carbapenemase (KPC-2) class A beta

114 Klebsiella pneumoniae carbapenemase-producing Enterobact

115 Vancomycin-resistant enterococci and Klebsiella pneumoniae carbapenemase-producing K. pneumon

116 in was effective for treating 24 of 26 (92%) Klebsiella pneumoniae carbapenemase-producing K. pneumon

117 the most common transmissible CPE worldwide, Klebsiella pneumoniae carbapenemase-producing K. pneumon

118 e performed on isolates to identify specific Klebsiella pneumoniae carbapenemases (KPC) and additiona

119 e, in contrast to metallo-beta-lactamases or Klebsiella pneumoniae carbapenemases (KPC), no specific

120 Klebsiella pneumoniae carbapenemases (KPCs) have recentl

121 Klebsiella pneumoniae carbapenemases (KPCs) were first i

122 Klebsiella pneumoniae carbapenemases (KPCs) were origina

123 fication of variants of carbapenem resistant Klebsiella pneumoniae carbapenemases and monitored by en

124 em-resistant Enterobacteriaceae that produce Klebsiella pneumoniae carbapenemases.

125 Klebsiella pneumoniae carriage frequencies were estimate

126 Klebsiella pneumoniae causes a wide range of infections,

127 Klebsiella pneumoniae causes severe lung and bloodstream

128 Klebsiella pneumoniae causing community-acquired pyogeni

129 teriaceae, primarily involving KPC-producing Klebsiella pneumoniae clonal complex CC258.

130 fecal material, resulting in eradication of Klebsiella pneumoniae compared with nonresponders.

131 nding global distribution of multi-resistant Klebsiella pneumoniae demands faster antimicrobial susce

132 Here we show that mice infected with Klebsiella pneumoniae develop lung injury with accumulat

133 scovery of a new enzyme, first identified in Klebsiella pneumoniae from a patient from New Delhi and

134 riable regions V3 and V6 were amplified from Klebsiella pneumoniae genomic DNA with blood in situ.

135 Klebsiella pneumoniae harboring blaKPC (KPC-Kpn) is ende

136 nst clinical isolates of Eschericia coli and Klebsiella pneumoniae harboring NDM-1 were reduced to su

137 Klebsiella pneumoniae has a reputation for causing a wid

138 lly track a clonal outbreak of blaKPC-pKpQIL-Klebsiella pneumoniae in a proof-of-principle study.

139 ogues with in vivo efficacy against MRSA and Klebsiella pneumoniae in animal models of infection.

140 a17 cell numbers in vivo, we used a model of Klebsiella pneumoniae in mice deficient in STAT6.

141 so show that expression of Gam in E. coli or Klebsiella pneumoniae increases sensitivity to fluoroqui

142 reported that host defense against pulmonary Klebsiella pneumoniae infection requires IL-22, which wa

143 zone to induce Paneth cell loss, followed by Klebsiella pneumoniae infection to induce intestinal inj

144 Carbapenem-resistant Klebsiella pneumoniae infections are increasingly preval

145 The increasing incidence of Klebsiella pneumoniae infections refractory to treatment

146 Klebsiella pneumoniae is a common colonizer of the gastr

147 Klebsiella pneumoniae is a common respiratory pathogen,

148 Klebsiella pneumoniae is an etiologic agent of community

149 Klebsiella pneumoniae is an opportunistic pathogen and l

150 Klebsiella pneumoniae is now recognized as an urgent thr

151 Klebsiella pneumoniae is part of the healthy human micro

152 Klebsiella pneumoniae is the most clinically relevant sp

153 esequencing of three plasmids in a reference Klebsiella pneumoniae isolate demonstrated approximately

154 Klebsiella pneumoniae isolated from screening swabs and

155 re prepared at various dilutions using three Klebsiella pneumoniae isolates containing blaNDM.

156 0% of Escherichia coli isolates and 24.2% of Klebsiella pneumoniae isolates globally, with rates reac

157 Klebsiella pneumoniae isolates harboring the K. pneumoni

158 ically-related NDM-1 carbapenemase producing Klebsiella pneumoniae isolates identified during an outb

159 bsiella pneumoniae carbapenemase (KPC) in 47 Klebsiella pneumoniae isolates using a novel automated m

160 tamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolates was evaluated.

161 prim-resistant clinical Escherichia coli and Klebsiella pneumoniae isolates, suggesting that they may

162 Klebsiella pneumoniae K1 is a major agent of hepatic abs

163 Escherichia coli PI-7, blaCTX-M-15-positive Klebsiella pneumoniae L7, and blaOXA-48-positive E. coli

164 Here, we show the increased prevalence of Klebsiella pneumoniae lipopolysaccharide O2 serotype str

165 Klebsiella pneumoniae liver abscess (KPLA) is prevalent

166 ential of bacteriophages in a mouse model of Klebsiella pneumoniae lobar pneumonia.

167 dministration of pathogenic bacteria, either Klebsiella pneumoniae or Salmonella enterica serovar Typ

168 (FMDV) veterinary outbreak in England and a Klebsiella pneumoniae outbreak in a Nepali neonatal unit

169 hese findings can help up better predict MDR Klebsiella pneumoniae outbreaks associated with specific

170 radrenergic neurons improves survival during Klebsiella pneumoniae peritonitis (67 versus 23%, p < 0.

171 We used a model of Klebsiella pneumoniae pneumonia in wild-type mice and mi

172 Klebsiella pneumoniae poses a major challenge to healthc

173 used by gram-negative pathogens, among which Klebsiella pneumoniae prominently features.

174 e-dependent protection of mice from a lethal Klebsiella pneumoniae pulmonary challenge.

175 Klebsiella pneumoniae remains an important cause of intr

176 Klebsiella pneumoniae resistance to third generation cep

177 cid-metabolizing gene cluster and pathway of Klebsiella pneumoniae revealed two major open reading fr

178 ed susceptibility to Escherichia coli K1 and Klebsiella pneumoniae sepsis in antibiotic-treated neona

179 Here, we investigate the process in Klebsiella pneumoniae serotype O12 (and Raoultella terri

180 nts performed in germfree mice infected with Klebsiella pneumoniae showed that these animals are dras

181 previously unsequenced multi-drug resistant Klebsiella pneumoniae strain BAA-2146 (KpnNDM).

182 For the rich mobilome of a hospital Klebsiella pneumoniae strain, circularization junctions

183 Carbapenem-resistant Klebsiella pneumoniae strains classified as multilocus s

184 ence of mcr-1 was investigated in E coli and Klebsiella pneumoniae strains collected from five provin

185 Klebsiella pneumoniae strains deleted for pal or lppA ex

186 Carbapenem-resistant Klebsiella pneumoniae strains that produce K. pneumoniae

187 ed as model pJHCMW1, a plasmid isolated from Klebsiella pneumoniae that includes two beta-lactamase a

188 ing the sequence type 258 (ST258) lineage of Klebsiella pneumoniae There was very little evidence of

189 zontal gene transfer (HGT) of blaOXA-48 from Klebsiella pneumoniae to Escherichia coli in an infected

190 acheally inoculated with either live or dead Klebsiella pneumoniae to induce either lung infection or

191 -derived sepsis caused by the human pathogen Klebsiella pneumoniae to study the role of platelets in

192 , as well as in a model of lung infection by Klebsiella pneumoniae Transferring serum from Ig-deficie

193 ) mice with the common human sepsis pathogen Klebsiella pneumoniae via the airways to induce pneumoni

194 -type and C/EBPdelta(-/-) mice infected with Klebsiella pneumoniae via the airways.

195 teria could reduce bacterial burden in vivo, Klebsiella pneumoniae was injected into the tail veins o

196 Klebsiella pneumoniae was isolated from retail meats fro

197 T CRE infection was identified in 59 (15.7%) Klebsiella pneumoniae was isolated in 83.2%; surgical si

198 sphoenolpyruvate carboxylase gene (ppc) from Klebsiella pneumoniae was overexpressed to access the on

199 ndogenous endophthalmitis is associated with Klebsiella pneumoniae whereas Coagulase negative Staphyl

200 During 2013, ST278 Klebsiella pneumoniae with blaNDM-7 was isolated from th

201 . aureus], 2 Stenotrophomonas maltophilia, 1 Klebsiella pneumoniae) and resulted in antimicrobial cha

202 Escherichia coli, Pseudomonas aeruginosa, or Klebsiella pneumoniae) isolated from clinical cases.

203 erococcus faecium, and beta-lactam-resistant Klebsiella pneumoniae).

204 thod was as follows; Escherichia coli, 100%; Klebsiella pneumoniae, 92.9%; Klebsiella oxytoca, 95.5%;

205 Klebsiella pneumoniae, a bacterial pathogen that has acq

206 Klebsiella pneumoniae, a chief cause of nosocomial pneum

207 ce were tail vein-injected with 10(8) CFU of Klebsiella pneumoniae, a common cause of EBE in diabetic

208 I agents, and multidrug-resistant strains of Klebsiella pneumoniae, a leading HAI agent, have caused

209 as historically largely been associated with Klebsiella pneumoniae, a predominant plasmid (pKpQIL), a

210 CutC GRE and the activating enzyme CutD from Klebsiella pneumoniae, a representative of the human mic

211 beta-lactam resistance in Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomo

212 In mice infected with NDM-1-expressing Klebsiella pneumoniae, AMA efficiently restored meropene

213 , Clostridium perfringens, Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecalis.

214 resistant Enterococcus, carbapenem-resistant Klebsiella pneumoniae, and Escherichia coli infection in

215 riggered by LPS from Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli Sixteen cyto

216 bacterium tuberculosis, Salmonella enterica, Klebsiella pneumoniae, and Escherichia coli We compare p

217 esistant pathogens such as Escherichia coli, Klebsiella pneumoniae, and Proteus spp.

218 of Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae, and Pseudomonas aeruginosa We the

219 Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa were t

220 cies-Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa-report

221 , Enterococcus faecalis, Klebsiella oxytoca, Klebsiella pneumoniae, and Staphylococcus aureus at age

222 ucosal challenge with the pulmonary pathogen Klebsiella pneumoniae, and substantially reduced epithel

223 portant carbapenem-resistant human pathogen, Klebsiella pneumoniae, by B. bacteriovorus in human seru

224 ial activity against E. coli, Salmonella and Klebsiella pneumoniae, comparing to the supercritical ex

225 am-negative bacteria on clinical isolates of Klebsiella pneumoniae, containing highly-resistant antim

226 The most common CRE species were Klebsiella pneumoniae, Enterobacter aerogenes, and Esche

227 ultidrug-resistant bacterial species such as Klebsiella pneumoniae, Enterobacter cloacae, Stenotropho

228 0.7%, respectively, caused by ESBL-producing Klebsiella pneumoniae, Escherichia coli, Klebsiella oxyt

229 the major uropathogens Proteus mirabilis and Klebsiella pneumoniae, in addition to UPEC, in humans.

230 lipopolysaccharide transporter LptB2FG from Klebsiella pneumoniae, in which both LptF and LptG are c

231 d in vivo during pneumoseptic infection with Klebsiella pneumoniae, indicating its regulatory role in

232 428) and 9,371 isolates of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, and Proteus m

233 ei, Chlamydia trachomatis, Escherichia coli, Klebsiella pneumoniae, Legionella pneumophila, Pseudomon

234 Carbapenem-resistant Klebsiella pneumoniae, most notably isolates classified

235 1%) of 5332 E coli isolates, 13 (<1%) of 348 Klebsiella pneumoniae, one (<1%) of 890 Enterobacter clo

236 ilis epsHIJK locus into pga-deleted E. coli, Klebsiella pneumoniae, or alginate-negative Pseudomonas

237 ter aerogenes, Enterobacter cloacae complex, Klebsiella pneumoniae, or Klebsiella oxytoca that were r

238 PS) of the multiresistant clinical strain of Klebsiella pneumoniae, PCM2713, and thus should be regar

239 chia coli/Shigella spp., Klebsiella oxytoca, Klebsiella pneumoniae, Proteus spp., Pseudomonas aerugin

240 Enterococcus faecium, Enterococcus faecalis, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acine

241 pathogens including Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Esche

242 f Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphyloc

243 , Bacillus subtilis, Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonellae typhi, Candida albica

244 wk and then challenged intratracheally with Klebsiella pneumoniae, Streptococcus pneumoniae, or lipo

245 o human pathogens, Staphylococcus aureus and Klebsiella pneumoniae, that utilize this metal nutrient

246 umonic sepsis using pulmonary infection with Klebsiella pneumoniae, the expression of MGL1 was upregu

247 In Klebsiella pneumoniae, the small basic connector protein

248 cation of DNA from Staphylococcus aureus and Klebsiella pneumoniae, two pathogens commonly related to

249 Inactivation of the apbE gene in Klebsiella pneumoniae, wherein the nqr operon and apbE a

250 coccus faecalis, Pseudomonas aeruginosa, and Klebsiella pneumoniae, which are frequently implicated i

251 ct infections by the Gram-negative bacterium Klebsiella pneumoniae, which is a proficient biofilm for

252 subjected to intra-abdominal infection with Klebsiella pneumoniae, which results in liver injury and

253 or in combination with Escherichia coli- or Klebsiella pneumoniae-induced pneumonia.

254 carbapenemase OXA-48, in lysate samples from Klebsiella pneumoniae.

255 verlapping AR genes, and are correlated with Klebsiella pneumoniae.

256 human pathogens Streptococcus pneumoniae and Klebsiella pneumoniae.

257 Staphylococcus aureus, Escherichia coli and Klebsiella pneumoniae.

258 cus faecium (VRE), and beta-lactam-resistant Klebsiella pneumoniae.

259 ssues of infected mice by the human pathogen Klebsiella pneumoniae.

260 are also active against MDR E. coli and MDR Klebsiella pneumoniae.

261 o lung infection by the major human pathogen Klebsiella pneumoniae.

262 richia coli O157:H7, and multidrug resistant Klebsiella pneumoniae.

263 eptible to infection by Escherichia coli and Klebsiella pneumoniae.

264 a variety of bacterial pathogens, including Klebsiella pneumoniae.

265 the rapid dissemination of a single clone of Klebsiella pneumoniae.

266 h diverse KPC producers not limited to ST258 Klebsiella pneumoniae.

267 ntibiotic-resistant metallo-beta-lactamase 1 Klebsiella pneumoniae.

268 in pathogenesis during bacteremia caused by Klebsiella pneumoniae.

269 clearance after intratracheal challenge with Klebsiella pneumoniae.

270 ed in the lung in response to infection with Klebsiella pneumoniae.

271 e development of multicellular aggregates of Klebsiella pneumoniae.

272 esistance enzyme that is normally present in Klebsiella pneumoniae.

273 ococcus faecium, Acinetobacter baumannii and Klebsiella pneumoniae.

274 activity against Acinetobacter baumannii and Klebsiella pneumoniae; however, analogue 9 and 16 at 4 m

275 spiked with approximately 1,500 CFU bla(KPC) Klebsiella pneumoniae; however, the detection rate dropp

276 ts play an important role in host defense to Klebsiella pneumosepsis.

277 er UTI and non-UTI bacteria, Staphylococcus, Klebsiella, Proteus and Shigella.

278 Our findings demonstrate that Klebsiella remodels its lipid A in a tissue-dependent ma

279 ntial importance in Escherichia, Salmonella, Klebsiella, Shigella, and Yersinia opportunistic pathoge

280 se negative staphylococci (CoNS) (33.5%) and Klebsiella species (4.7%).

281 ghly informative screening tool that detects Klebsiella species and identifies clinically important s

282 resistance rates for some organisms, such as Klebsiella species and Pseudomonas aeruginosa, were lowe

283 Klebsiella species are members of the family enterobacte

284 e with bacteremia due to Escherichia coli or Klebsiella species from October 2008 to March 2015 at Jo

285 d reintroduction of single Staphylococcus or Klebsiella species was sufficient to inhibit B. pertussi

286 dime in P. aeruginosa and for carbapenems in Klebsiella species) to 3.0 (for piperacillin-tazobactam

287 patients were 277 for P. aeruginosa, 174 for Klebsiella species, and 106 for Enterobacter species.

288 in the respiratory tract with P. aeruginosa, Klebsiella species, or Enterobacter species susceptible

289 o had HO bacteremia due to Escherichia coli, Klebsiella species, or Pseudomonas aeruginosa at 130 VHA

290 in Escherichia coli, from 11.8% to 90.5% in Klebsiella spp and from 30.4% to 71.9% in other Enteroba

291 5% to 31.1% in E coli, from 1.7% to 70.2% in Klebsiella spp and from 5.9% to 68.8% in other Enterobac

292 tobiotic techniques, we show that strains of Klebsiella spp. isolated from the salivary microbiota ar

293 rmidis) and gram-negative (Escherichia coli, Klebsiella spp., Pseudomonas aeruginosa, Enterococcus ae

294 ndophthalmitis caused by a wzyAKpK1-positive Klebsiella strain in a U.S. resident, raising concern fo

295 These Klebsiella strains are resistant to multiple antibiotics

296 Science, Atarashi et al. (2017) showed that Klebsiella strains isolated from the saliva of Crohn's d

297 oughput gain-of-function screen to examine a Klebsiella transposon mutant library.

298 Among other virulence factors in Klebsiella, type 3 pili exhibit a unique binding pattern

299 BC-GN assay were subsequently identified as Klebsiella variicola.

300 f a depleting antibody in mice infected with Klebsiella via the airways.